241 related articles for article (PubMed ID: 18369777)
21. The impact of target site accessibility on the design of effective siRNAs.
Tafer H; Ameres SL; Obernosterer G; Gebeshuber CA; Schroeder R; Martinez J; Hofacker IL
Nat Biotechnol; 2008 May; 26(5):578-83. PubMed ID: 18438400
[TBL] [Abstract][Full Text] [Related]
22. Design and validation of siRNAs and shRNAs.
Tilesi F; Fradiani P; Socci V; Willems D; Ascenzioni F
Curr Opin Mol Ther; 2009 Apr; 11(2):156-64. PubMed ID: 19330721
[TBL] [Abstract][Full Text] [Related]
23. Ablation of Stat3 by siRNA alters gene expression profiles in JEG-3 cells: a systems biology approach.
Jiang K; Krous LC; Knowlton N; Chen Y; Frank MB; Cadwell C; Centola M; Jarvis JN
Placenta; 2009 Sep; 30(9):806-15. PubMed ID: 19616846
[TBL] [Abstract][Full Text] [Related]
24. 3' UTR seed matches, but not overall identity, are associated with RNAi off-targets.
Birmingham A; Anderson EM; Reynolds A; Ilsley-Tyree D; Leake D; Fedorov Y; Baskerville S; Maksimova E; Robinson K; Karpilow J; Marshall WS; Khvorova A
Nat Methods; 2006 Mar; 3(3):199-204. PubMed ID: 16489337
[TBL] [Abstract][Full Text] [Related]
25. Mechanistic insights aid computational short interfering RNA design.
Boese Q; Leake D; Reynolds A; Read S; Scaringe SA; Marshall WS; Khvorova A
Methods Enzymol; 2005; 392():73-96. PubMed ID: 15644176
[TBL] [Abstract][Full Text] [Related]
26. On the art of identifying effective and specific siRNAs.
Pei Y; Tuschl T
Nat Methods; 2006 Sep; 3(9):670-6. PubMed ID: 16929310
[TBL] [Abstract][Full Text] [Related]
27. Many commonly used siRNAs risk off-target activity.
Snøve O; Holen T
Biochem Biophys Res Commun; 2004 Jun; 319(1):256-63. PubMed ID: 15158470
[TBL] [Abstract][Full Text] [Related]
28. [RNA interference--towards individualized genetic medicine].
Corydon TJ; Mikkelsen JG
Ugeskr Laeger; 2006 Dec; 168(50):4401-4. PubMed ID: 17217865
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of cell-based arrays using micropatterned alkanethiol monolayers for the parallel silencing of specific genes by small interfering RNA.
Fujimoto H; Yoshizako S; Kato K; Iwata H
Bioconjug Chem; 2006; 17(6):1404-10. PubMed ID: 17105217
[TBL] [Abstract][Full Text] [Related]
30. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
Takahashi Y; Nishikawa M; Takakura Y
Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
[TBL] [Abstract][Full Text] [Related]
31. dsCheck: highly sensitive off-target search software for double-stranded RNA-mediated RNA interference.
Naito Y; Yamada T; Matsumiya T; Ui-Tei K; Saigo K; Morishita S
Nucleic Acids Res; 2005 Jul; 33(Web Server issue):W589-91. PubMed ID: 15980542
[TBL] [Abstract][Full Text] [Related]
32. A universal RNAi-based logic evaluator that operates in mammalian cells.
Rinaudo K; Bleris L; Maddamsetti R; Subramanian S; Weiss R; Benenson Y
Nat Biotechnol; 2007 Jul; 25(7):795-801. PubMed ID: 17515909
[TBL] [Abstract][Full Text] [Related]
33. A probability-based approach for the analysis of large-scale RNAi screens.
König R; Chiang CY; Tu BP; Yan SF; DeJesus PD; Romero A; Bergauer T; Orth A; Krueger U; Zhou Y; Chanda SK
Nat Methods; 2007 Oct; 4(10):847-9. PubMed ID: 17828270
[TBL] [Abstract][Full Text] [Related]
34. Knock-down of gene expression in hematopoietic cells.
Scherr M; Venturini L; Eder M
Methods Mol Biol; 2009; 506():207-19. PubMed ID: 19110629
[TBL] [Abstract][Full Text] [Related]
35. Endogenous small RNAs in grain: semi-quantification and sequence homology to human and animal genes.
Ivashuta SI; Petrick JS; Heisel SE; Zhang Y; Guo L; Reynolds TL; Rice JF; Allen E; Roberts JK
Food Chem Toxicol; 2009 Feb; 47(2):353-60. PubMed ID: 19068223
[TBL] [Abstract][Full Text] [Related]
36. State-of-the-art modified RNAi compounds for therapeutics.
Carstea ED; Hough S; Wiederholt K; Welch PJ
IDrugs; 2005 Aug; 8(8):642-7. PubMed ID: 16044372
[TBL] [Abstract][Full Text] [Related]
37. Cloning and characterization of small non-coding RNAs from grape.
Carra A; Mica E; Gambino G; Pindo M; Moser C; Pè ME; Schubert A
Plant J; 2009 Sep; 59(5):750-63. PubMed ID: 19453456
[TBL] [Abstract][Full Text] [Related]
38. RNA interference in pain research.
Röhl T; Kurreck J
J Neurochem; 2006 Oct; 99(2):371-80. PubMed ID: 17029593
[TBL] [Abstract][Full Text] [Related]
39. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
[TBL] [Abstract][Full Text] [Related]
40. Stat3 as a molecular target in RNA interference-based treatment of oral squamous cell carcinoma.
Klosek SK; Nakashiro K; Hara S; Goda H; Hamakawa H
Oncol Rep; 2008 Oct; 20(4):873-8. PubMed ID: 18813829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
